Transgene SA
TRGNF
$0.85
-$0.15-15.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.50% | -- | |||
| Total Other Revenue | -0.43% | -43.89% | |||
| Total Revenue | -0.43% | -40.81% | |||
| Cost of Revenue | -0.43% | -8.05% | |||
| Gross Profit | 0.43% | -3.20% | |||
| SG&A Expenses | -0.43% | -3.93% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.43% | 2,232.03% | |||
| Total Operating Expenses | -0.43% | -1.79% | |||
| Operating Income | 0.43% | -8.68% | |||
| Income Before Tax | 0.43% | 2.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.43% | 2.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.43% | 2.68% | |||
| EBIT | 0.43% | -8.68% | |||
| EBITDA | 0.43% | -8.74% | |||
| EPS Basic | 0.44% | 17.55% | |||
| Normalized Basic EPS | 0.24% | 17.64% | |||
| EPS Diluted | 0.44% | 19.98% | |||
| Normalized Diluted EPS | 0.24% | 17.64% | |||
| Average Basic Shares Outstanding | 0.00% | 18.14% | |||
| Average Diluted Shares Outstanding | 0.00% | 18.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||